INO – Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

INO

$2.06

Name : Inovio Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $141,528,944.00

EPSttm : -2.72

Inovio Pharmaceuticals, Inc.

$2.06

3.29%

$0.07

Float Short %

12.63

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.1

EPS Last/This Y

1.6

EPS This/Next Y

0.86

Price

2.06

Target Price

7.63

Analyst Recom

1.67

Performance Q

-9.65

Relative Volume

0.64

Beta

1.61

Ticker: INO

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	INO	1.96	0.03	0.36	26882
2025-11-14	INO	2.06	0.04	0.06	27653
2025-11-17	INO	1.98	0.04	0.08	26980
2025-11-18	INO	1.89	0.04	0.32	27123
2025-11-19	INO	1.78	0.04	0.49	27444
2025-11-20	INO	1.72	0.04	0.98	27646
2025-11-21	INO	1.77	0.05	0.05	27886
2025-11-24	INO	1.81	0.06	0.00	17454
2025-11-25	INO	1.815	0.05	0.00	19910
2025-11-26	INO	1.97	0.04	0.03	21980
2025-12-01	INO	1.92	0.04	0.01	21539
2025-12-02	INO	1.91	0.04	0.37	21838
2025-12-03	INO	2.015	0.05	0.14	21967
2025-12-04	INO	2.02	0.05	0.04	22194
2025-12-05	INO	2.07	0.05	0.05	22256
2025-12-08	INO	2.1	0.05	0.16	22043
2025-12-09	INO	2.17	0.05	0.71	22341
2025-12-10	INO	2.17	0.05	0.15	22610
2025-12-11	INO	2.13	0.05	1.24	22514
2025-12-12	INO	2.06	0.06	1.72	22560
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	INO	1.96	46.5	-	-2.05
2025-11-14	INO	2.06	40.0	-	-2.41
2025-11-17	INO	1.99	43.3	-	-2.36
2025-11-18	INO	1.89	43.3	-	-2.36
2025-11-19	INO	1.78	43.3	-	-2.36
2025-11-20	INO	1.73	43.3	-	-2.36
2025-11-21	INO	1.76	40.8	-	-2.35
2025-11-24	INO	1.81	40.8	-	-2.35
2025-11-25	INO	1.81	40.8	-	-2.35
2025-11-26	INO	1.97	40.8	-	-2.35
2025-12-01	INO	1.91	40.8	-	-2.35
2025-12-02	INO	1.92	40.8	-	-2.35
2025-12-03	INO	2.02	40.8	-	-2.35
2025-12-04	INO	2.03	40.8	-	-2.35
2025-12-05	INO	2.07	40.8	-	-2.35
2025-12-08	INO	2.09	40.8	-	-2.35
2025-12-09	INO	2.18	40.8	-	-2.35
2025-12-10	INO	2.18	40.8	-	-2.35
2025-12-11	INO	2.13	40.8	-	-2.35
2025-12-12	INO	2.06	40.8	-	-2.35
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	INO	0.00	-6.05	0
2025-11-14	INO	0.00	-6.05	15.41
2025-11-17	INO	0.00	1.34	0
2025-11-18	INO	0.00	1.34	12.37
2025-11-19	INO	0.00	1.34	0
2025-11-20	INO	0.00	1.34	12.02
2025-11-21	INO	0.00	1.34	12.02
2025-11-24	INO	0.00	11.76	12.02
2025-11-25	INO	0.00	11.76	12.02
2025-11-26	INO	0.00	11.76	12.09
2025-12-01	INO	0.00	11.76	12.09
2025-12-02	INO	0.00	11.76	12.09
2025-12-03	INO	0.00	11.76	12.09
2025-12-04	INO	0.00	11.76	12.09
2025-12-05	INO	0.00	11.76	12.09
2025-12-08	INO	0.00	11.76	12.09
2025-12-09	INO	0.00	11.76	12.09
2025-12-10	INO	0.00	11.76	12.63
2025-12-11	INO	0.00	11.76	12.63
2025-12-12	INO	0.00	11.76	12.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="INO" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.44

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.34

Insider Transactions

Institutional Transactions

11.76

Beta

1.61

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.1

Max Drawdown 5-Year %

-99.4

Target Price

7.63

P/E

Forward P/E

PEG

P/S

786.28

P/B

P/Free Cash Flow

EPS

-2.58

Average EPS Est. Cur. Y

-2.35

EPS Next Y. (Est.)

-1.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-59281.69

Relative Volume

0.64

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.3

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”INO” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”INO” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Inovio Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 134

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

stock quote shares INO – Inovio Pharmaceuticals, Inc. Stock Price stock today

news today INO – Inovio Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch INO – Inovio Pharmaceuticals, Inc. yahoo finance google finance

stock history INO – Inovio Pharmaceuticals, Inc. invest stock market

stock prices INO premarket after hours

ticker INO fair value insiders trading

INO – Inovio Pharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: INO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y